Correlation of angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by angiotensin- converting enzyme inhibitor

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 8, Issue 1, 2003, Pages 25-30

  Li, Xiaotao ^a   Du, Yanmei ^b   Du, Yanfang ^b   Huang, Xizheng ^a  

^a HEBEI GENERAL HOSPITAL   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; Antihypertensive response; Insertion deletion polymorphism; Polymerase chain reaction

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0344951235     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840300800i105     Document Type: Article

References (27)

1. Barley J, Blackwood A, Miller M, et al. Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens 10:31, 1996
2. Duru K, Farrow S, Wang JM, et al. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African -Americans with hypertension. Am J Hypertens 7:759, 1994
3. Vassilikioti S, Doumas M, Petidis K, et al. Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. Am J Hypertens 9:700, 1996
4. Schmidt S, van Hooft IM, Grobbee DE, et al. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 11:345, 1993
5. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343, 1990
6. Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin-converting enzyme in the human heart: Effect of the deletion/insertion polymorphism. Circulation 92:1387, 1995
7. Baudin B. Angiotensin I-converting enzyme gene polymorphism and drug response. Clin Chem Lab Med 38:853, 2000
8. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 153:154, 1993
9. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and likage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197, 1992
10. Chiang FT, Lai ZP, Chern TH, et al. Lack of association of the angiotensin converting enzyme polymorphism with essential hypertension in a Chinese population. Am J Hypertens 10:197, 1997
11. Cao W, Ling SS, Zhang QC, et al. Angiotensin-converting enzyme gene polymorphism in untreated essential hypertension and response to angiotensin converting enzyme inhibitors. Acta Pharmaceutica Sinica 34:655, 1999
12. Ishigami T, Iwamota T, Tamura K, et al. Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan. Ethnic difference of ACE genotype. Am J Hypertension 8:95, 1995
13. Jian M, Huang J, Qi J, et al. Polymorphism of angiotensin I converting enzyme gene in the older Chinese: linked to ambulatory blood pressure levels and circadian blood pressure rhythm. Int J Cardiol 55:33, 1996
14. Chiang FT, Chem TH, Lai ZP, et al. Age- and gender-dependent association of the angiotensin-converting enzyme gene with essential hypertension in a Chinese population. J Hum Hypertens 10:823, 1996
15. SL Wu, SR Feng, KB Li, et al. Correlation of angiotensin converting enzyme genes type with the effect of antihypertensive treatment by captopril. Chin J Hypertens 9:296, 2001
16. Stavroulakis GA, Makris TK, Krespi PG, et al. Predicting response to chronic antihypertensive treatment with fosinopril: The role of angiotensin-converting enzyme gene polymorphism. Cardiovasc Drugs Ther 14:427, 2000
17. Ueda S, Meredith PA, Morton JJ, et al. ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (Enalaprilat) in humans. Circulation 98:2148, 1998
18. Danser AH, Derkx FH, Hense HW, et al. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens 16:1879, 1998
19. Prasad A, Narayanan S, Husain S, et al. Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition. Circulation 102:35, 2000
20. Buikema H, Pinto YM, Rooks G, et al. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 17:787, 1996
21. Ueda S, Elliott HL, Morton JJ, et al. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25:1266, 1995
22. Brown NJ, Blais C, Gandhi SK, et al. ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol 32:373, 1998
23. Gainer JV, Morrow JD, Loveland A, et al. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 339:1285, 1998
24. Bouaziz H, Joulin Y, Safar M, et al. Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition. Br J Pharmacol 113:717, 1994
25. Barbe F, Su JB, Guyene TT, et al. Bradykinin pathway is involved in acute hemodynamic effects of enalaprilat in dogs with heart failure. Am J Physiol 270:H1985, 1996
26. Morris BJ, Zee RYL, Schrader A. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest 94:1085, 1994
27. Dieguez-Lucena JL, Aranda-Lara P, Ruiz-Galdon M, et al. Angiotensin I-converting enzyme genotypes and angiotensin (receptors. Response to therapy. Hypertension 28:98, 1996